window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 24, 2026

  • News
  • About Us
Contact Us

AI in Pharma

  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Digital Health,Pharmaceuticals and therapeutics,Technology and platforms

    From outputs to outcomes: Saama’s Derek Lawrence on why clinical data management must change

    Clinical data management is under pressure to evolve as trials [...]

    January 20, 2026
  • Artificial Intelligence,Biotech,Drug Development,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    January 13, 2026
  • Artificial Intelligence,Data Management,Digital Health,Healthcare leadership,Market Access & Commercialization,Pharmaceuticals and therapeutics,Technology and platforms

    Veeva announces expanded partnership with Roche to deliver next-generation AI CRM

    Veeva Systems has extended its partnership with Roche Pharmaceuticals by [...]

    November 24, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Clinical studies,Market Access & Commercialization

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    November 13, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,Peptides,Research & Development

    Solvias CSO Danny Galbraith on peptides, ADCs and AI driving drug development innovation

    Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

    November 7, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Clinical Development,Data Management,Partnerships & Funding

    IQVIA and Veeva agree global clinical and commercial collaboration

    IQVIA and Veeva Systems have announced the resolution of all [...]

    August 30, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Regulatory Affairs

    Advarra launches AI engine to enhance operational efficiency in clinical trials

    Advarra has introduced Braid, an artificial intelligence (AI) engine designed [...]

    August 12, 2025
  • Market Access & Commercialization,Patient Centricity,Technology and platforms

    Pharma’s digital reckoning: Why SEO is now a strategic imperative

    With growing debate over a potential ban on DTC TV [...]

    July 29, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Research & Development,Technology and platforms

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    July 25, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development,Technology and platforms

    PhoreMost unveils breakthrough platform to rationalise molecular glue drug discovery

    High-throughput GlueSEEKER platform expands druggable space by identifying novel induced [...]

    July 22, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study
    Categories: Uncategorised
  • Datwyler, LTS Device Technologies, and Stevanato Group collaborate on large-volume self-administration solutions
    Categories: Biologics & Biosimilars, Drug Delivery & Formulation, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
  • NeuroVice seizure oral injury device now available through BlinkRx
    Categories: Central Nervous System, Digital Health, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top